Celebrating One Year of Biorizon Consulting
This month, Biorizon Consulting marks its first anniversary — a milestone that reflects not only growth, but the strategic impact we have begun to make in the life sciences ecosystem.
Founded in early 2024, Biorizon Consulting was built on a clear vision: to be the place where innovation meets expertise — accelerating early-stage life science breakthroughs by combining scientific rigour, commercial insight, and curated investor access.
Our first year has been defined by:
Designing preclinical strategies for biotech and MedTech innovators, leveraging deep scientific expertise to position research for successful clinical translation.
Driving targeted investor engagement by refining pitches, strengthening commercial narratives, and facilitating cross-border introductions — particularly between Europe and Southeast Asia.
Showcasing innovation internationally with our first Biorizon Consulting booth in Germany, reinforcing our commitment to representing transformative science on the global stage.
We also launched two strategic service lines to sharpen our impact:
Biorizon Insight – delivering in-depth market, scientific, and competitive intelligence to guide strategic decision-making.
Biorizon Elevate – enhancing fundraising outcomes through investor readiness programmes, pitch refinement, and strategic positioning.
Our platform now includes nearly 300 active investors across HealthTech, MedTech, Tech, therapeutics, and diagnostics. We are currently collaborating with three MedTech companies and one Biotech on investor matchmaking — and we have the capacity to onboard one additional startup seeking to raise capital.
For founders, this means a partner who can bridge the gap between science and capital. For investors, it means access to highly curated, high-quality opportunities — not mass mailings.
Looking Ahead
In year two, we will continue to strengthen the Europe–Southeast Asia investment corridor while building a direct bridge to U.S. capital markets. Our aim remains clear: to deliver robust scientific and commercial strategies that ensure innovation reaches the patients and markets that need it most.
Biorizon Consulting’s first year has been one of building foundations. The next will be about scaling impact, continuing to be the place where innovation meets expertise.
If you are a founder raising capital for early-stage life science innovation or an investor seeking targeted opportunities, we invite you to connect.
Here’s to the next chapter of accelerating life science innovation, together.